The integration between cardiology and oncology, with individualized risk stratification and longitudinal follow-up, are essential for reducing cardiovascular morbidity and mortality among breast cancer patients and survivors.
This review explores the cardiovascular [CV] implications of modern breast cancer treatments, including chemotherapy, endocrine therapy, targeted agents, radiotherapy, and emerging modalities such as immunotherapy and highlights the impact of patient-specific factors—such as diabetes, lipid profile, and treatment durat...
F. Felicetti, G. Mittica, C. Cavallin et al.· Endocrines· 0 citations
It is recommended that patients with lung cancer undergo screening to assess their cardiovascular risk and related complications and it is recommended that patients with lung cancer undergo screening to assess their cardiovascular risk and related complications.
M. Mamedov, P. Skopin, A. K. Karimov· Russian Journal of Preventiv...· 0 citations
Evaluating the occurrence of new-onset CVD in women with breast cancer undergoing chemotherapy and identifying factors associated with increased risk of cardiovascular disease highlights the need for sustained cardiovascular surveillance in breast cancer survivors.
V. Dvorovy, L. Kováčová, M. Selvek et al.· European Heart Journal, Supp...· 0 citations
Women with non-metastatic breast cancer frequently present with suboptimal control of cardiovascular risk factors at the time of qualification for anticancer therapy, and cardio-oncology care should focus on optimal blood pressure management and aggressive modification of metabolic risk factors, including obesity and d...
S. Mędrek, S. Szmit· European Heart Journal, Supp...· 0 citations
Cardio-oncology has emerged as a critical discipline in modern medicine due to the growing population of cancer survivors and the increasing recognition of cardiovascular disease as a major cause of morbidity and mortality in this population. While there have been significant advances in chemotherapy such as advances i...
Aryan Gajjar, S. Shah, A. Gajjar et al.· Biomedicines· 0 citations
By integrating biochemical, imaging, dosimetric, and predictive modeling approaches, clinicians may better balance oncologic efficacy with cardiovascular safety, reduce long-term cardiac morbidity, and improve overall outcomes in patients undergoing contemporary multimodality treatment for esophageal cancer.
U. Anosike, Roy Olunga, Emmanuel Korir et al.· Foregut: The Journal of the...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.